LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2026/1968 of 7 September 2026 renewing the approval of the active substance phosphine in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Commission Implementing Regulation (EU) 2026/1968 of 7 September 2026 renewing the approval of the active substance phosphine in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Implementing Regulation (EU) 2026/1968 · Regulation · 5 articles

In force

Version history

Data as of 2026-10-01 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Renewal of the approval of the active substance

Article 1

Open ↗

The approval of the active substance phosphine, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.

Amendments to Implementing Regulation (EU) No 540/2011

Article 2

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force and date of application

Article 3

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 October 2026.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Phosphine/Phosphane (no ISO common name allocated) CAS No: 7803-51-2 CIPAC No: 127 Phosphine 970 g/kg 1 October 2026 30 September 2041 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on phosphine, and in particular Appendices I and II thereto, shall be taken into account. When granting authorisations for plant protection products containing phosphine, Member States shall pay particular attention to eliminate any exposure of humans, animals and the environment to phosphine. For that purpose, when authorising plant protection products, the following conditions and restrictions shall be imposed: — application of products shall only be carried out by well-trained authorised personnel, possessing the corresponding certificate of competence and fumigation licences according to the respective national legislation, — application of products shall only be carried out in gas-tight chambers or rooms and gas tightness of the chamber or room is tested, and the fumigation is initiated by supplying phosphine into the chamber or room from outside, — a safety zone shall be established from which all persons must be evacuated, and it must be monitored with appropriate certified detection devices that a concentration of 0,01 ppm for PH3 in the air at the border of the zone is not exceeded, to ensure protection of bystanders and residents, — entering the treated chambers or rooms shall be prohibited. However, in case of emergency personal protective equipment must be worn by operators and workers entering treated chambers, for example self-contained breathing apparatus (SCBA), — it must be ensured that, following fumigation, remaining phosphine is pumped off by special filter technology suitable for capturing phosphine to ensure that no phosphine is emitted into the environment, — fumigation shall only be considered fully complete once the phosphine level in the air of the treated chamber or room is below the limit of detection (0,01 ppm of PH3), — products present in the chamber or room during treatment shall only be removed after ventilation if phosphine residue concentrations in these products are at or below LOQ levels, — treated containers shall not be transported until fumigation is fully completed. The applicant shall submit to the Commission, the Member States and the Authority the following confirmatory information about the potential genotoxicity of phosphine: (1) either information confirming, on the basis of existing studies or scientific literature, that genotoxicity testing of phosphine in vivo is not appropriate because: (a) the observed severe clinical symptoms or the mortality resulting from exposure to phosphine are expected to prevent a clear interpretation of the results as regards specifically genotoxicity; and (b) positive genotoxicity results are only observed close to high toxicity concentrations, based on dose-response or mode of action analysis; (2) or, if the information in point (1) cannot be provided, a new in vivo Micronucleus test by inhalation following short-term exposure according to the OECD Test Guidelines 474. The applicant shall submit to the Commission, the Member States and the Authority the requested confirmatory information by 28 September 2028. ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

ANNEX IISupplementary provisions

Open ↗

ANNEX II In Part B of the Annex to Implementing Regulation (EU) No 540/2011, row 28 on phosphane is replaced by the following: No Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘28 Phosphine/Phosphane (no ISO common name allocated) CAS No: 7803-51-2 CIPAC No: 127 Phosphine 970 g/kg 1 October 2026 30 September 2041 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on phosphine, and in particular Appendices I and II thereto, shall be taken into account. When granting authorisations for plant protection products containing phosphine, Member States shall pay particular attention to eliminate any exposure of humans, animals and the environment to phosphine. For that purpose, when authorising plant protection products, the following conditions and restrictions shall be imposed: — application of products shall only be carried out by well-trained authorised personnel, possessing the corresponding certificate of competence and fumigation licences according to the respective national legislation, — application of products shall only be carried out in gas-tight chambers or rooms and gas tightness of the chamber or room is tested, and the fumigation is initiated by supplying phosphine into the chamber or room from outside, — a safety zone shall be established from which all persons must be evacuated and it must be monitored with appropriate certified detection devices that a concentration of 0,01 ppm for PH3 in the air at the border of the zone is not exceeded, to ensure protection of bystanders and residents, — entering the treated chambers or rooms shall be prohibited. However in case of emergency personal protective equipment must be worn by operators and workers entering treated chambers, for example self-contained breathing apparatus (SCBA), — it must be ensured that, following fumigation, remaining phosphine is pumped off by special filter technology suitable for capturing phosphine to ensure that no phosphine is emitted into the environment, — fumigation shall only be considered fully complete once the phosphine level in the air of the treated chamber or room is below the limit of detection (0,01 ppm of PH3), — products present in the chamber or room during treatment shall only be removed after ventilation if phosphine residue concentrations in these products are at or below LOQ levels, — treated containers shall not be transported until fumigation is fully completed. The applicant shall submit to the Commission, the Member States and the Authority the following confirmatory information about the potential genotoxicity of phosphine: (1) either information confirming, on the basis of existing studies or scientific literature, that genotoxicity testing of phosphine in vivo is not appropriate because: (a) the observed severe clinical symptoms or the mortality resulting from exposure to phosphine are expected to prevent a clear interpretation of the results as regards specifically genotoxicity; and (b) positive genotoxicity results are only observed close to high toxicity concentrations, based on dose-response or mode of action analysis; (2) or, if the information in point (1) cannot be provided, a new in vivo Micronucleus test by inhalation following short-term exposure according to the OECD Test Guidelines 474. The applicant shall submit to the Commission, the Member States and the Authority the requested confirmatory information by 28 September 2028.’ ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

Other acts of the same type
Commission Implementing Regulation (EU) 2020/1993 of 4 December 2020 authorising the placing on the market of selenium-containing yeast (Yarrowia lipolytica) biomass as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1995 of 4 December 2020 amending Implementing Regulation (EU) No 2018/1261 as regards administrative changes of the information related to the Union authorisation of the biocidal product family ‘Hypred’s iodine based products’ (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/139 of 4 December 2020 amending Annexes I and V to Regulation (EU) 2019/125 concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment to take into account the withdrawal of the United Kingdom from the UnionCommission Delegated Regulation (EU) 2021/269 of 4 December 2020 amending Delegated Regulation (EU) 2020/427 as regards the date of application of the amendments to certain detailed production rules for organic products in Annex II to Regulation (EU) 2018/848 of the European Parliament and of the Council (Text with EEA relevance)Commission Regulation (EU) 2020/1819 of 2 December 2020 amending Annex II to Regulation (EC) No 1333/2008 of the European Parliament and of the Council as regards the use of colours in salmon substitutes (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1820 of 2 December 2020 authorising the placing on the market of dried Euglena gracilis as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1821 of 2 December 2020 authorising the placing on the market of an extract from Panax notoginseng and Astragalus membranaceus as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1822 of 2 December 2020 authorising the placing on the market of chromium-containing yeast (Yarrowia lipolytica) biomass as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1823 of 2 December 2020 amending Regulation (EU) No 234/2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food flavourings (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1824 of 2 December 2020 amending Implementing Regulation (EU) 2017/2468 laying down administrative and scientific requirements concerning traditional foods from third countries in accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on novel foods (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1825 of 2 December 2020 amending Articles 7 and 8 of Implementing Regulation (EU) 2019/2072 as regards temporary measures for the introduction into, or movement within, the Union territory of certain plants, plant products or other objectsCommission Implementing Regulation (EU) 2020/1992 of 2 December 2020 amending Regulation (EC) No 474/2006 as regards the list of air carriers banned from operating or subject to operational restrictions within the Union (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next